Publications

Hogan Lovells Publications

Regulatory Insights for Life Sciences and Health Care Investments: Regulatory changes in Europe

Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars.

Hogan Lovells Publications

Understanding sunshine rules: how new transparency regulations in Europe are changing relationships between industry and health care professionals

The 2010 Physician Payments Sunshine Act created a new standard of transparency for financial relationships between pharmaceutical companies and health care professionals in the U.S. Now,...

Hogan Lovells Publications

Connecting Europe - False advertising in life sciences

In view of the success of our first edition of “False Advertising in Life Sciences”, we are proud to introduce our second edition which is even more thorough.

Hogan Lovells Publications

Life sciences and health care horizons

Hogan Lovells Publications

Pharmaceutical pricing key priority for Dutch Competition Authority in 2018-2019

Pricing of medicinal products continues to be a hot topic in the Netherlands, not only in political debate or from a regulatory and reimbursement perspective, but also from a competition...

Hogan Lovells Publications

EU Pricing & Reimbursement Newsletter

Welcome to this special edition of the Hogan Lovells EU Pricing & Reimbursement newsletter.

;
Loading data